Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 7D Surgical, Abingdon Health, Ethicon, Quest Diagnostics, Seegene.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adocia, Astrazeneca, Aytu, Bluebird, BMS, Celltrion, Direct, Diurnal, Dynacure, Edesa, Eton, Imago, Marinus, Merck, Poxel, Siga, Sumitomo, Synthetic, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hai Kang, Philips, Sinapi Biomedical, Truvian.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Emmaus, Inovio, Melt, Merck, Novartis, Regulus, Relief, Ridgeback, Roche, Scynexis, Teva.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Arcturus, Beigene, Can-Fite, Celltrion, Diffusion, Generex, Genor, Inotrem, Kyowa Kirin, Mesoblast, Neoimmunetech, Redhill.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neocis, Nowdiagnostics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apogenix, Black Diamond, Chi-Med, Foresee, Hemoshear, Larimar, Momenta, Nabriva, Protara, Realta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Color, Labcorp, Rapid Medical, Stratus Medical, Zebra Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, Can-Fite, Carisma, Celltrion, Checkmate, Diffusion, Eton, Generex, Gilead, Kite, Kyowa, Merus, Neoimmunetech, Ocugen, Oculis, Pharmacyte, Scpharmaceuticals, Solid.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adaptimmune, Astrazeneca, Biomarin, Blueprint, Galapagos, Gilead, Heron, Insmed, Kyowa Kirin, Miragen, Myokardia, Novartis, Oncoceutics, Sarepta, Vistagen.